UNSPSC 85818608: Transfusion of nonautologous plasma cryoprecipitate into products of conception, circulatory, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous plasma cryoprecipitate into products of conception, circulatory, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30273M1

UNSPSC 85818608 Transfusion of nonautologous plasma cryoprecipitate into products of conception, circulatory, percutaneous approach is a Commodity code that shows little relevant recent activity in state and local procurement. The recent opportunities tagged under this code span independent medical evaluations for public safety pension disability determinations, surgical benefit program carve-outs for municipal employees, occupational medical surveillance for state ferry workers, emergency and specialty medical services for detained youth, pharmacy benefit management administration, and temporary health professional staffing — none of which involve transfusion procedures, cryoprecipitate products, or the specific clinical interventions the code nominally describes. The tagging appears to reflect a classification mismatch rather than genuine procurement activity aligned with the code's clinical scope.

State and local buyers posting under this code include city retirement offices, municipal human resources departments, state transportation agencies, county juvenile justice systems, county health consortiums, and county health systems across Arizona, California, Florida, Washington, and Texas. The recent solicitations represent administrative and staffing services for public-sector health benefits and occupational health programs rather than medical product procurement or clinical transfusion services. No opportunities in the source material reflect actual purchasing of blood products, plasma derivatives, or related clinical supplies that would align with the code's nominal scope. Given the mismatch between the code's technical definition and what state and local governments are actually buying under it, the code does not represent a viable pursuit vector for vendors in the transfusion or plasma-product space.